Kim YB - Search Results

1

Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases.

Sousa-Lima I, Kim HJ, Jones J, Kim YB. Sousa-Lima I, et al. Among authors: kim hj, kim yb. Diabetes Metab J. 2021 Sep;45(5):655-674. doi: 10.4093/dmj.2021.0197. Epub 2021 Sep 30. Diabetes Metab J. 2021. PMID: 34610720 Free PMC article. Review.

2

Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects.

Kim YB, Ciaraldi TP, Kong A, Kim D, Chu N, Mohideen P, Mudaliar S, Henry RR, Kahn BB. Kim YB, et al. Among authors: kim d. Diabetes. 2002 Feb;51(2):443-8. doi: 10.2337/diabetes.51.2.443. Diabetes. 2002. PMID: 11812753 Clinical Trial.

3

Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.

Kim YB, Kotani K, Ciaraldi TP, Henry RR, Kahn BB. Kim YB, et al. Diabetes. 2003 Aug;52(8):1935-42. doi: 10.2337/diabetes.52.8.1935. Diabetes. 2003. PMID: 12882908

4

Role of Rho-kinase in regulation of insulin action and glucose homeostasis.

Furukawa N, Ongusaha P, Jahng WJ, Araki K, Choi CS, Kim HJ, Lee YH, Kaibuchi K, Kahn BB, Masuzaki H, Kim JK, Lee SW, Kim YB. Furukawa N, et al. Among authors: kim jk, kim hj, kim yb. Cell Metab. 2005 Aug;2(2):119-29. doi: 10.1016/j.cmet.2005.06.011. Cell Metab. 2005. PMID: 16098829 Free article.

5

Targeted disruption of ROCK1 causes insulin resistance in vivo.

Lee DH, Shi J, Jeoung NH, Kim MS, Zabolotny JM, Lee SW, White MF, Wei L, Kim YB. Lee DH, et al. Among authors: kim ms, kim yb. J Biol Chem. 2009 May 1;284(18):11776-80. doi: 10.1074/jbc.C900014200. Epub 2009 Mar 10. J Biol Chem. 2009. PMID: 19276091 Free PMC article.

6

In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.

Chun KH, Choi KD, Lee DH, Jung Y, Henry RR, Ciaraldi TP, Kim YB. Chun KH, et al. Among authors: kim yb. Am J Physiol Endocrinol Metab. 2011 Mar;300(3):E536-42. doi: 10.1152/ajpendo.00538.2010. Epub 2010 Dec 28. Am J Physiol Endocrinol Metab. 2011. PMID: 21189360 Free PMC article.

7

Rho-kinase regulates energy balance by targeting hypothalamic leptin receptor signaling.

Huang H, Kong D, Byun KH, Ye C, Koda S, Lee DH, Oh BC, Lee SW, Lee B, Zabolotny JM, Kim MS, Bjørbæk C, Lowell BB, Kim YB. Huang H, et al. Among authors: kim ms, kim yb. Nat Neurosci. 2012 Oct;15(10):1391-8. doi: 10.1038/nn.3207. Epub 2012 Sep 2. Nat Neurosci. 2012. PMID: 22941110 Free PMC article.

8

Metabolic actions of Rho-kinase in periphery and brain.

Huang H, Lee DH, Zabolotny JM, Kim YB. Huang H, et al. Among authors: kim yb. Trends Endocrinol Metab. 2013 Oct;24(10):506-14. doi: 10.1016/j.tem.2013.06.003. Epub 2013 Aug 10. Trends Endocrinol Metab. 2013. PMID: 23938132 Free PMC article. Review.

9

ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance.

Lee SH, Huang H, Choi K, Lee DH, Shi J, Liu T, Chun KH, Seo JA, Lima IS, Zabolotny JM, Wei L, Kim YB. Lee SH, et al. Among authors: kim yb. Am J Physiol Endocrinol Metab. 2014 Feb;306(3):E332-43. doi: 10.1152/ajpendo.00619.2013. Epub 2013 Dec 10. Am J Physiol Endocrinol Metab. 2014. PMID: 24326423 Free PMC article.

10

SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle.

Koo YD, Choi JW, Kim M, Chae S, Ahn BY, Kim M, Oh BC, Hwang D, Seol JH, Kim YB, Park YJ, Chung SS, Park KS. Koo YD, et al. Among authors: kim m, kim yb. Diabetes. 2015 Jul;64(7):2420-31. doi: 10.2337/db15-0115. Epub 2015 Mar 17. Diabetes. 2015. PMID: 25784542 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,294 results

Search Page